Trials / Conditions / Monoclonal Antibody

Monoclonal Antibody

4 registered clinical trials studyying Monoclonal Antibody — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastro NCT06532006	Shanghai Henlius Biotech	Phase 3
Unknown	Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With Poly NCT05428410	Beijing Tongren Hospital	—
Completed	Efficacy of Montelukast in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Re NCT04198623	University of California, San Francisco	Phase 2
Completed	VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal NCT01950325	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1